Neovasc (NVCN) –
-
Volato Announces Changes to Board Composition
-
Form 6-K NEOVASC INC For: Apr 12
-
Form 6-K NEOVASC INC For: Apr 11
-
Form RW NEOVASC INC
-
Form F-10POS NEOVASC INC
-
Form POS AM NEOVASC INC
-
Form S-8 POS NEOVASC INC
-
Form 25-NSE NEOVASC INC Filed by: Nasdaq Stock Market LLC
-
Form 6-K NEOVASC INC For: Apr 11
-
Shockwave Medical Completes Acquisition of Neovasc
-
Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update
-
Form 6-K NEOVASC INC For: Mar 09
-
Form 6-K NEOVASC INC For: Mar 06
-
Neovasc Shareholders Approve Acquisition by Shockwave Medical
-
Neovasc Shareholders Approve Acquisition by Shockwave Medical
-
Form 6-K NEOVASC INC For: Feb 10
-
Form 6-K NEOVASC INC For: Feb 01
-
Neovasc (NVCN) Announces German Reimbursement Renewal
-
Neovasc Announces German Reimbursement Renewal
-
Form 6-K NEOVASC INC For: Jan 27
-
Form 6-K NEOVASC INC For: Jan 18
-
H.C. Wainwright Downgrades Neovasc (NVCN) to Neutral
-
Form 6-K NEOVASC INC For: Jan 16
-
Form 6-K NEOVASC INC For: Jan 17
-
Shockwave Medical to Acquire Neovasc
-
Neovasc (NVCN) to Resume Trading at 8:30 a.m.
-
Shockwave Medical (SWAV) Acquires Neovasc (NVCN) for $27.25/sh + $12 CVR
-
Shockwave Medical to Acquire Neovasc (NVCN) for Over $27.25 Per Share
-
Shockwave Medical to Acquire Neovasc
-
Shockwave Medical Announces Agreement to Acquire Neovasc
-
Neovasc (NVCN) Halted, News Pending
-
Form 6-K NEOVASC INC For: Nov 28
-
Neovasc Announces Progress on COSIRA-II Clinical Trial
-
Neovasc (NVCN) Announces Progress on COSIRA-II Clinical Trial
-
Neovasc Announces Progress on COSIRA-II Clinical Trial
-
Neovasc (NVCN) Comments on European Heart Journal Publication
-
Form 6-K NEOVASC INC For: Nov 18
-
Neovasc Comments on European Heart Journal Publication
-
Neovasc Comments on European Heart Journal Publication
-
Neovasc (NVCN) Misses Q3 EPS by 60c
-
Form 6-K NEOVASC INC For: Sep 30
-
Neovasc Announces Third Quarter Financial Results and Provides Corporate Update
-
Neovasc Announces Third Quarter Financial Results and Provides Corporate Update
-
Form 6-K NEOVASC INC For: Nov 08
-
Neovasc (NVCN) Reducer Obtains U.S. Outpatient Reimbursement
-
Neovasc Reducer Obtains U.S. Outpatient Reimbursement
-
Neovasc Reducer Obtains U.S. Outpatient Reimbursement
-
Form 6-K NEOVASC INC For: Oct 27
-
Neovasc to Report Third Quarter Financial Results on November 10, 2022
-
Neovasc to Report Third Quarter Financial Results on November 10, 2022
Back to NVCN Stock Lookup